Scientific articles

Old fashioned Book RechercheHere are links to scientific magazines on-line with articles that directly relate to our work on a therapeutic vaccines for autoimmune diseases

 

 

Complementary peptide vaccine in Myasthenia Gravis (MG).

Possible Therapeutic Vaccines for Canine Myasthenia Gravis: Implication for the Human Disease and Associated Fatigue

Galin, F. Shawn , Cheryl L. Chrisman, James R. Cook Jr., Likang Xu, Patricia L. Jackson, Brett D. Noerager, Nathaniel M. Weathington and J. Edwin Blalock

Brain, Behavior, and Immunity, Volume 21, Issue 3, March 2007, Pages 323-331

http://dx.doi.org/10.1016/j.bbi.2006.10.001

Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network

Weathington, Nathaniel M. and J. Edwin Blalock

Expert Review of Vaccines, Vol. 2, No. 1, Pages 61-73, 2003

http://www.future-drugs.com/doi/pdf/10.1586/14760584.2.1.61

The Role of Adjuvants in the Efficacy of a Peptide vaccine for Myasthenia Gravis

McAnally, James L. , Likang Xu, Matteo Villain and J.Edwin Blalock

Exp Biol Med Vo. 226(4): 307-311, 2001

http://www.ebmonline.org/cgi/reprint/226/4/307.pdf

Prevention and Reversal of Experimental Autoimmune Myasthenia Gravis by a Monoclonal Antibody against Acetylcholine Receptor-Specific T Cells

Xu, L., M. Villain, F.S. Galin, S. Araga, and J.E. Blalock.

Cellular Immunology 208, 107-114, 2001

http://dx.doi.org/10.1006/cimm.2001.1777

A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help

Araga, Shigeru , Likang Xu, Kenji Nakashima, Matteo Villain and J. Edwin Blalock

FASEB J. 14: 185-196, 2000

http://www.fasebj.org/cgi/reprint/14/1/185.pdf

Prevention of Experimental Autoimmune Myasthenia Gravis by a Monoclonal Antibody to a Complementary Peptide for the Main Immunogenic Region of the Acetylcholine Receptor

Araga, S., F.S. Galin, M. Kishimoto, A. Adachi, and J.E. Blalock.

The Journal of Immunology, 157: 386-392, 1996

http://www.jimmunol.org/cgi/reprint/157/1/386.pdf

Use of Complementary Peptides and Their Antibodies in B-Cell-Mediated Autoimmune Disease: Prevention of Experimental Autoimmune Myasthenia Gravis with a Peptide Vaccine

Araga, S. and J.E. Blalock.

IMMUNOMETHODS 5, 130-135, 1994

http://dx.doi.org/10.1006/immu.1994.1047

Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor

Araga, S., R.D. LeBoeuf and J.E. Blalock.

Proc. Natl. Acad. Sci. USA Vol. 90 Immunology, 8747-8751, 1993

http://www.pnas.org/cgi/content/abstract/90/18/8747

Complementary peptide vaccine in Multiple Sclerosis (MS)

 An IgM anti-MBP Ab in the case of Waldenstrom’s macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE

Brett D. Noerager, Takashi Inuzuka, Jun-ichi Kira, J.Edwin Blalock, John N. Whitaker, F.Shawn Galin.

Journal of Neuroimmunology 113, 163-169, 2001

http://www.journals.elsevierhealth.com/periodicals/jni/article/PIIS0165572800004252/abstract

Highly related immunoglobulin light chain sequences in different multiple sclerosis patients

J.Edwin Blalock, Shan-Ren Zhou, Curtis C Maier, F.Shawn Galin, John N Whitaker.

Journal of Neuroimmunology 100, 98-101, 1999

http://www.ncbi.nlm.nih.gov/pubmed/10695719

Active immunization with complementary peptide PBM 9-1: Preliminary evidence that it modululates experimental allergic encephalomyelitis in PL/J Mice and Lewis Rats

Zhou S-R, Whitaker JN.

J. Neurosci. Res. 45, 439–446, 1996

http://www.ncbi.nlm.nih.gov/pubmed/10695719

Specific modulation of T-cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies

Zhou S-R, Whitaker JN.

J. Immunol. 150, 1629–1642, 1993

http://www.jimmunol.org/cgi/content/abstract/150/4/1629

Complementary peptide vaccine in Guillain-Barré Syndrome (GBS)

A complementary Peptite Vaccine That Induces T Cell Anergy and Prevents Experimental Allergic Neuritis in Lewis Rats

Araga, Shigeru, Masahiro Kishimoto, Sotoko Doi and Kenji Nakashima

Journal of Immunology, 163: 476-482, 1999

http://www.jimmunol.org/cgi/reprint/163/1/476.pdf